Studies have found that downregulation of the JAK1/STAT3 pathway can reduce proinflammatory cytokines, MMPs inhibition, and inflammatory cell apoptosis, thereby alleviating the clinical symptoms of RA (Wang et al., 2018). Here, JAK1 is linked to rheumatoid arthritis.